SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral surges on commissioning first Chlorotoluenes Value Chain facility in Gujarat

24 Mar 2025 Evaluate

Epigral is currently trading at Rs. 1980.20, up by 52.55 points or 2.73% from its previous closing of Rs. 1927.65 on the BSE.

The scrip opened at Rs. 1927.65 and has touched a high and low of Rs. 2022.00 and Rs. 1915.25 respectively. So far 6255 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2408.35 on 03-Oct-2024 and a 52 week low of Rs. 1034.80 on 22-Mar-2024.

Last one week high and low of the scrip stood at Rs. 2022.00 and Rs. 1760.25 respectively. The current market cap of the company is Rs. 8597.42 crore.

The promoters holding in the company stood at 68.94%, while Institutions and Non-Institutions held 7.34% and 23.72% respectively.

Epigral has successfully commissioned India’s first Chlorotoluenes Value Chain Facility at its Dahej Complex in Gujarat on March 24, 2025. This facility will further strengthen the company’s integrated complex and will supply intermediates for pharmaceutical and agrochemical industries.

Epigral, formerly known as Meghmani Finechem, is a leading integrated manufacturer of chemicals in India.

Epigral Share Price

1115.00 51.35 (4.83%)
12-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
SRF 2708.60
BASF India 3351.65
Tata Chemicals 746.60
Pidilite Inds. 1527.50
Deepak Nitrite 1672.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: